These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34517454)

  • 21. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.
    Noguchi R; Kaji K; Namisaki T; Moriya K; Kitade M; Takeda K; Kawaratani H; Okura Y; Aihara Y; Furukawa M; Mitoro A; Yoshiji H
    World J Gastroenterol; 2017 Sep; 23(36):6705-6714. PubMed ID: 29085215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
    Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
    World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
    Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
    World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The diagnostic potential of Golgi protein 73 for cirrhosis in patients with chronic hepatitis C].
    Wang PF; Liu SH; Qian XJ; Zhai XW; Wen XJ; Yao MJ; Zhao FM; Lu F
    Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):879-884. PubMed ID: 36207945
    [No Abstract]   [Full Text] [Related]  

  • 25. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
    Yue W; Li Y; Geng J; Wang P; Zhang L
    Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Establishment and evaluation of noninvasive diagnostic models for liver fibrosis in patients with chronic hepatitis B].
    Yang Q; Liu DP; Li LP; Gu Y; Zhang MX; Liu Y; Yang K
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):15-20. PubMed ID: 28297773
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical value of noninvasive method in diagnosing hepatic fibrosis about chronic HBV carriers].
    Zhang XY; Qian J; Li P; Hu LH; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):332-336. PubMed ID: 29996199
    [No Abstract]   [Full Text] [Related]  

  • 28. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective comparison of transient elastography, point shear wave elastography, APRI and FIB-4 for staging liver fibrosis in chronic viral hepatitis.
    Udompap P; Sukonrut K; Suvannarerg V; Pongpaibul A; Charatcharoenwitthaya P
    J Viral Hepat; 2020 Apr; 27(4):437-448. PubMed ID: 31799740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.
    Wu X; Cai B; Su Z; Li Y; Xu J; Deng R; Wang L
    J Clin Lab Anal; 2018 May; 32(4):e22341. PubMed ID: 29251384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
    Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
    Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B].
    Liang CF; Chang YN; Peng XR; He Y; Chen M; Peng ML; Hu P; Ren H; Xu HM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):551-557. PubMed ID: 34225430
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
    Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
    Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.
    Li B; Zhang L; Zhang Z; Yan G; Zhu L; Lu W; Yu H
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):218-223. PubMed ID: 30277926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
    Wang J; Chen Z; Yan X; Yang Y; Liu Y; Chen Y; Jia B; Xia J; Xiong Y; Zhang Z; Ding W; Huang R; Wu C
    Discov Med; 2019 Sep; 28(153):149-158. PubMed ID: 31926586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a potential biomarker to improve the assessment of liver fibrosis progression in patients with chronic hepatitis B.
    Chen J; Yu S; Lang Z; Jin Y; Zhou G; Tao Q; Wang X; Zheng J
    J Med Virol; 2023 Jan; 95(1):e28239. PubMed ID: 36258661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Alpha-Fetoprotein as a Predictor of Liver Fibrosis in HBeAg-Positive Chronic Hepatitis B Patients.
    Yang K; Pan Y; Liu L; Sun B; Shi W
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241155
    [No Abstract]   [Full Text] [Related]  

  • 38. The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B.
    Zhong LK; Zhang G; Luo SY; Yin W; Song HY
    J Clin Lab Anal; 2020 Jul; 34(7):e23270. PubMed ID: 32363594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel noninvasive index for the prediction of moderate to severe fibrosis in chronic hepatitis B patients.
    Li J; Mao RC; Li XL; Zheng JW; Qi X; Yuan Q; Zhang J; Zhang JM; Xia NS
    Dig Liver Dis; 2018 May; 50(5):482-489. PubMed ID: 29396134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.